Mavenclad - direct healthcare professional communication (DHPC)

cladribine
DHPCHuman

Bulgarian is available via eTranslation, the European Commission's machine translation service.

Translate to Bulgarian | Important information about machine translation

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Документи

Direct healthcare professional communication (DHPC): Mavenclad (cladribine) – risk of serious liver injury and new recommendations about liver function monitoring

English (EN) (143.58 KB - PDF)

Публикувано за първи път:
Виж

Key facts

Medicine name
Mavenclad
Active substance
cladribine
Therapeutic area (MeSH)
Multiple Sclerosis
Regulatory outcome
Variation
DHPC type
Adverse event
Human ATC codes
L04AA40
Dissemination date

Share this page